CI_with has_Ingredient has_MoA has_PE may_prevent may_treat Lipoxygenase Inhibitors [MoA] Glucocorticoid Receptor Agonists [MoA] Autoimmune Diseases [Disease/Finding] Drug Hypersensitivity [Disease/Finding] Graft vs Host Disease [Disease/Finding] Hematologic Diseases [Disease/Finding] Hypersensitivity [Disease/Finding] Inflammation [Disease/Finding] Neoplasms [Disease/Finding] Neurologic Manifestations [Disease/Finding] Respiratory Distress Syndrome, Adult [Disease/Finding] Skin Diseases, Infectious [Disease/Finding] Methylprednisolone [Chemical/Ingredient] Carbohydrate Metabolism Alteration [PE] Decreased Glucocorticoid Secretion [PE] Decreased Leukotriene Activity [PE] Decreased Prostaglandin Activity [PE] Decreased Protein Synthesis [PE] Decreased Thromboxane Activity [PE] Lipid Metabolism Alteration [PE] Lysosomal Function Alteration [PE] Infant [Disease/Finding] Decreased Polymorphonuclear Leukocyte Migration [PE] Decreased Fibroblast Migration [PE] Decreased Capillary Permeability [PE] M [Preparations] METHYLPREDNISOLONE 6902 Active C17198 METHYLPREDNISOLONE Ingredient 4018068 Methylprednisolone X4W7ZR7023 N0000146409 <VANDF_Record>50.6^394^</VANDF_Record><VA_File>50.6</VA_File><VA_IEN>394</VA_IEN> C0025815 <VANDF_Record>50.416^665^</VANDF_Record><VA_File>50.416</VA_File><VA_IEN>665</VA_IEN>